What the labels say about food
All four labels pair the drug with a diet and leave the diet undefined. Zepbound is indicated in combination with a reduced-calorie diet and increased physical activity (Zepbound Prescribing Information, revised January 2026), and Wegovy carries the same words (Wegovy Prescribing Information, revised February 2026). None of the four prints a calorie number, a list of foods, or a meal pattern for you.
The closest thing to a number is how the trials were run. In the Zepbound weight trials, everyone received instruction on a reduced-calorie diet of approximately a 500 kcal/day deficit and physical activity counseling with a recommended minimum of 150 minutes a week (Zepbound Prescribing Information, January 2026). The Wegovy trials used the same deficit and the same 150 minutes (Wegovy Prescribing Information, February 2026). Those figures describe the studies, and your own number comes from your prescriber or dietitian.
The labels do answer two practical questions. Ozempic, Mounjaro, Zepbound, and the Wegovy injection can each be taken with or without food (each Medication Guide, 2025 to 2026). Semaglutide and tirzepatide both delay gastric emptying, and the Zepbound label says the delay is largest after the first dose and diminishes over time (Zepbound Prescribing Information, January 2026; Wegovy Prescribing Information, February 2026).
NIDDK puts the relationship plainly: medications don't replace physical activity or healthy eating habits as a way to lose weight (NIDDK, Prescription Medications to Treat Overweight and Obesity, last reviewed June 2024). The NHS says you'll need to eat a healthy, balanced diet while using semaglutide or tirzepatide (NHS Medicines, last reviewed 15 May 2026).


